SAGILITY

Date: July 21, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir/Ma’am, Sub: Submission of Investor Presentation to be made to investors on July 21, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In continuation of our letter dated July 13, 2026, please find enclosed the presentation to be made to investors on the financial results of Sagility Limited for the quarter ended June 30, 2026, during the meeting scheduled today, i.e., Tuesday, July 21, 2026, at 7:30 p.m. (IST). The details are also being made available on the Company’s website https://sagility.com/ This is for your information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008 Encl: a/a Sagility Limited (Formerly Sagility India Limited, earlier Sagility India Private Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Safe Harbor Certain statements in this release concerning Sagility’s future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company. Performance Highlights Q1 FY27 Business Insights Adjusted Adjusted Revenue ▶ 27.3% Y-o-Y organic growth in Q1 FY27, driven by expansion within existing clients and rising EBITDA PAT contribution from FY26 new client wins ₹ 19,635 ₹ 4,716 ₹ 2,697 ▶ Won $35.3M of steady state ACV in Q1 FY27, driven by expansion opportunities / new SOWs across 18 Million Million Million US$207.8M US $49.9M US$28.6M existing clients and 1 new logo ▶ Acquired CareSeed to strengthen our position in healthcare quality, especially for Medicare Advantage YoY growth % Margin % Margin % 27.6% 24.0% 13.7% plans, thereby adding differentiated analytics and HEDIS capabilities while expanding our platform depth and mid-market reach. Added 26 new clients via CareSeed acquisition 15.2% in CC YoY growth % YoY YoY ▶ Increases in statutory minimum wages in Karnataka and Telangana, effective 22nd May 2026 and 1st June (Excl. CareSeed) growth % growth % 2026 respectively 27.3% 27.9% 35.1% 14.9% in CC Rewards & Recognitions Sagility India has been ranked 11th among India’s 100 Best Companies Major Contender – Healthcare Customer to Work For 2026 by Great Place to Experience Management (CXM) Intelligent Leader – Avasant Clinical and Work® India Operations PEAK Matrix® Assessment Care Management Business 2026 Process Transformation 2026 RadarViewTM Recognized by ET Edge as Best Major Contender – Revenue Cycle Management Organizations for Women (RCM) Intelligent Operations PEAK Matrix® Assessment 2026 KPIs Q1 FY27 Q4 FY26 Q1 FY26 YoY% TTM Jun’26 TTM Jun’25 YoY% Revenue from Operation (in ₹ M) 19,635 20,243 15,389 27.6% 76,174 58,855 29.4% Steady state Revenue 19,635 17,983 15,389 27.6% 71,647 57,154 25.4% Seasonal Revenue (Open Enrollment) - 2,260 - 4,527 1,701 166.2% Revenue by Vertical Split By Payer % 89.6% 90.8% 88.4% 89.9% 89.2% By Provider % 10.4% 9.2% 11.6% 10.1% 10.8% Growth in revenue from operation (%) 27.6% 29.1% 25.8% 29.4% 21.1% Adjusted EBITDA* (in ₹ M) 4,716 5,036 3,687 27.9% 19,228 15,456 24.4% Adjusted EBITDA % 24.0% 24.9% 24.0% 25.2% 26.3% Adjusted PAT** (in ₹ M) 2,697 3,069 1,997 35.1% 12,006 8,657 38.7% Adjusted PAT % 13.7% 15.2% 13.0% 15.8% 14.7% Total Number of Employees at the end of period 47,307 46,860 39,917 18.5% 47,307 39,917 18.5% Voluntary attrition rate^ (%) 28.6% 38.1% 27.6% 30.5% 27.5% Note: *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI , BroadPath & CareSeed), share-based payment awards and excludes other income (including forex gain/loss). **Adjusted PAT reflects EBITDA adjustments and adjustments for amortization of intangible assets arising from the carve-out of the healthcare business from HGS, as well as the statutory impact of increase in Minimum wages in Karnataka & Telangana, net of tax ^Voluntary attrition is calculated for employees with tenure exceeding 90 days and presented on an annualized basis, derived from voluntary exits during the respective quarter Annual KPIs Q1 FY27 FY26 FY25 FY24 FY23 Numbers of Client group* Active 109 82 75 44 35 Number of new client addition 27** 17 38 13 7 Delivery Sites Number of delivery sites 29 31 33 30 27 New site addition (Gross) - 4 10 4 2 TTM Jun26 FY26 FY25 FY24 FY23 Client groups contribution to revenues Top 3 Client % 60.1% 59.9% 66.2% 68.3% 72.4% Top 5 Client % 70.1% 70.4% 77.9% 79.2% 80.6% Top 10 Client % 84.1% 83.9% 90.5% 91.4% 90.7% Number of Million-dollar client groups Number of clients contributing more than US$ 20M 9 9 7 5 4 Number of clients contributing to US$ 5M - US$ 20M 8 7 6 7 7 Number of clients contributing to US$ 1M - US$ 5M 21 21 12 12 12 Number of clients contributing less than US$ 1M 71 45 50 20 12 *Client groups comprise client entities together with their affiliates. **30 clients added via CareSeed acquisition – 26 new client groups, 2 common client groups, 2 affiliates of existing client groups Sagility-CareSeed A unified end-to-end quality operations continuum CareSeed, founded in 2012 and headquartered in Kansas City, Missouri, is a U.S.-based healthcare analytics company. CareSeed solutions include Forecast, which provides HEDIS reporting and quality analytics, and Harvest, which delivers cloud-based medical record review, chart abstraction, and supplemental data capture capabilities. + ~$5.1MN ~95% 31.4% 30 14 CY25 Revenue Recurring Revenue CY25 EBITDA Margin Small & mid payer clients Team members By combining CareSeed’s technology with Sagility’s healthcare operations, clinical Capability Technology Cross-sell Talent services, and AI-led Strengthens Sagility's NCQA-certified Forecast Expands market reach Specialized talent position in Quality for and Harvest platforms with 26 new small & mid- strengthens capabilities transformation Medicare Advantage advance Sagility's shift sized health plans plus 2 across quality technology, capabilities, Sagility will (MA) - expanding from retrospective HEDIS subsidiaries of existing and client management - deliver an end-to-end capabilities across reporting to AI-led, clients - creating backed by strong, HEDIS, CMS Stars, quality integrated quality immediate cross-sell and established health-plan quality operations reporting, and care-gap operations. greater wallet share via an relationships. continuum. orchestration. integrated, tech-led BPaaS model. Sagility–CareSeed: End-to-End Quality Operations Continuum Care Gap Abstraction HEDIS Care Gap Quality of care Population Provider identification & management encounter audit Closure impact analysis health program success Prioritization & validation enablement CareSeed Technology and Analytics Sagility Technology and Analytics • Forecast • Gap identification- Careseed core expertise • Harvest AI Enabled Analytics • Risk stratified chase list creation Workflow • Care Gap/ Population health/ AIP platform 360° QUALITY OF CARE • RN Abstraction & Scalable Outreach (Onshore/Offshore/Digital) + Care Coordination • Robust Operational oversight Services Compliance • HEDIS File Submission • Behavior change framework driving long term health • Star measurement & audit tracking adoption • Coding validation with provider Equipping Health plans to move beyond HEDIS reporting to member-level orchestration, while unlocking STAR improvement and revenue uplift Future Proofing Payer Operations Independent research validates the healthcare market trends driving demand for Sagility’s AI and domain-led healthcare operations model. Key Finding What It Means Payers face mounting cost, workforce, and By the Numbers regulatory pressures Redesigning workflows before agentic implementation a necessity for meaningful 70% have adopted AI; only 10% report impact • 50 payer leaders measurable improvement surveyed 70% identify domain-led intelligent operations • 94% expect AI + as a priority Deep domain knowledge is required for workflow human oversight design Healthcare expertise remains the vital • 84% report limited AI foundation for payers value today Understanding of the complete payer ecosystem Payer expectations are shifting toward and willingness to commit to outcomes become strategic partners key criteria in partner decisions. Sagility engaged Everest Group to conduct focused research on the payer market trends and factors influencing partnership choices across 50 decision makers in the payer organizations. Financial Highlights Q1 FY27 delivered strong growth at steady margins, and strong cash generation - a strong start to the year ₹ 19,635 ₹ 4,716 ₹ 2,697 ₹ 3,161 Million Million Million Million YoY growth % Margin % Margin % Conversion % 27.6% 24.0% 13.7% 69.9% 15.2% in CC YoY growth % (Excl. CareSeed) YoY Growth % YoY Growth % DSO 27.3% 27.9% 35.1% 80 days 14.9% in CC Quarterly Seasonality Revenue Mix and Adjusted EBITDA Margin % $200.0 35.0% $181.8 $172.0 33.0% $10.3 2 months of % $9.7 BroadPath 31.0% n $150.0 Revenue ig )M 26.1% 26.6% ($8.9M) 24.0% In m c o lu n d th e s o f 3 29.0% r a M $ ( e u $100.0 23.8% 28.4% B r r e o v a e d n P u a e th 2 2 5 7 . . 0 0 % % A D T n ($11.3M) IB e v 23.0% E e d R $146.6 $157.9 $162.3 $171.5 $180.4 21.0% e t $50.0 s u 19.0% jd A 17.0% $0.0 15.0% Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 $250.0 35.0% $222.0 $222.1 33.0% $24.8 $25.2 % $200.0 31.0% n 29.0% ig r )M a M $ ( e $150.0 24.0% 24.9% 24.0% 27.0% A D u 26.2% 26.0% 25.0% T n e v e $100.0 C In a c re lu S d e e e s d 23.0% IB E d R effective 11th e $180.4 $189.4 $196.8 $197.3 $207.8 Jun’26 ($0.4M 2 ) 1.0% t s u $50.0 19.0% jd A 17.0% $0.0 15.0% Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Steady State Revenue ($M) Seasonal Revenue ($M) Adjusted EBITDA Margin Our Revenues exhibit seasonality. Q3 & Q4 have seasonal Revenues from Open Enrolment and AEP Long Term Financial Performance Snapshot Revenue (₹M) FY25 FY26 Adj. EBITDA* (₹M) FY25 FY26 Adj. PAT(₹M) FY25 FY26 (growth % Y-o-Y) 17.2% 29.1% (growth % Y-o-Y) 28.4% 23.9% (growth % Y-o-Y) 37.5% 39.5% ₹76,174 ₹71,929 ₹55,699 ₹18,200 ₹19,228 ₹11,306 ₹12,006 ₹47,536 ₹14,685 ₹8,107 ₹11,436 ₹5,896 FY24 FY25 FY26 TTM Jun26 FY24 FY25 FY26 TTM Jun26 FY24 FY25 FY26 TTM Jun26 Stronger adjusted PAT supported by lower finance cost Revenue ($M) FY25 FY26 Adj. EBITDA* ($M) FY25 FY26 Adj. PAT ($M) FY25 FY26 (growth % Y-o-Y) 14.9% 23.6% (growth % Y-o-Y) 25.9% 18.7% (growth % Y-o-Y) 34.8% 33.5% $814.0 $841.3 $206.0 $212.6 $658.3 $173.6 $127.9 $133.1 $572.9 $137.8 $95.8 $71.1 FY24 FY25 FY26 TTM Jun26 FY24 FY25 FY26 TTM Jun26 FY24 FY25 FY26 TTM Jun26 14 *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI, BroadPath, & CareSeed), share-based payment awards and exclude other income (including forex gain/loss). Other Financial Indicators Adjusted EPS (in ₹) Adjusted ROCE % 2.56 2.42 58.9% 58.6% 54.9% 1.76 47.0% 1.38 FY24 FY25 FY26 TTM Jun26 FY24 FY25 FY26 TTM Jun26 Cash Conversion (%) Net Debt 1.90x ₹30,000 89.7% 87.2% 0.71x 80.5% ₹25,000 ₹21,678 70.8% 69.9% 64.7% ₹20,000 0.11x 54.4% 53.4% ₹15,000 ₹10,433 0.06x ₹10,000 ₹5,000 ₹1,962 ₹1,110 FY24 FY25 FY26 Q1 FY27 ₹0 FY24 FY25 FY26 TTM Jun26 OCF % FCF % Net Debt (in ₹ Million) Q1 FY27 Cash Conversion at 69.9% impacted by acquisition-related earnout payments Adjusted EPS is Adjusted PAT divided by weighted average number of equity shares 15 Adjusted ROCE is Adjusted PAT plus Interest cost divided by capital employed (Assets excluding goodwill and intangibles assets less current liabilities) Net Debt is Borrowing plus lease liabilities less Cash and Cash equivalent including investment in Mutual Fund and Deposits . Borrowing doesn’t include accrued interest Q1 FY27 Consolidated Profit and Loss Amount in ₹ M Particulars Q1 FY27 Q4 FY26 Q1 FY26 YoY% QoQ% Revenue from Operation 19,635 20,243 15,389 27.6% -3.0% Steady state Revenue 19,635 17,983 15,389 27.6% 9.2% Seasonal Revenue (Open Enrollment) - 2,260 - - - Employee benefits expense* 12,154 12,580 9,646 Minimum Wage impact 70 - - ▶ Statutory minimum wage hikes. Q1 FY27 (~40 days impact Other expenses^ 2,694 2,627 2,056 ₹70M). Margin impact estimated Adjusted EBITDA** 4,716 5,036 3,687 27.9% -6.4% at ~1.2% of revenues for FY27 Adjusted EBITDA % 24.0% 24.9% 24.0% Adjustments: ▶ Q1 FY27 Forex loss of ₹283M was driven by foreign exchange M&A Earnouts -8 150 155 hedges. SAR (stock appreciation right) – Non Cash 60 39 71 Other Income^^ 143 82 50 ▶ Exceptional Item: Statutory Forex Gain / (Loss) -283 166 49 Impact of Past service costs towards Gratuity and Reported EBITDA 4,525 5,094 3,560 27.1% -11.2% Compensated absence. Finance costs 219 221 274 Depreciation and amortisation 1,280 1,242 1,182 Profit Before exceptional item 3,026 3,632 2,104 43.8% -16.7% Statutory impact of Minimum Wage increase in Karnataka and 151 - - - - Telangana Profit Before Tax 2,875 3,632 2,104 36.6% -20.8% Tax Expenses 707 1,055 618 Reported Profit After Tax 2,168 2,577 1,486 45.9% -15.9% EPS 0.46 0.56 0.32 45.9% -15.9% Adjusted PAT 2,697 3,069 1,997 35.1% -12.1% Adjusted PAT % 13.7% 15.2% 13.0% Adjusted EPS (₹) 0.58 0.66 0.43 35.1% -12.1% *Employee benefits expense excludes M&A earnout and SAR (shown separately under adjustments), ^ Other expenses exclude forex loss, ^^ Other income excludes forex gain. Forex Gain and Forex Loss clubbed together and shown separately. ** Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI, BroadPath & CareSeed), share-based payment awards and exclude other income (including forex gain/loss). Adjustments on EBITDA and PAT 3500 Adj EBITDA Bridge: Q1 FY27 (₹M) Adj PAT Bridge: Q1 FY27 (₹M) ₹140 ₹4,716 3000 ₹113 ₹2,697 ₹363 ₹60 ₹4,525 2500 -₹8 ₹2,168 ₹60 -₹6 2000 1500 RepoReporterd EBITtDAed Adj A Adj B Other iOthner Income/Fcx gainome/ AdAjdjusteud EBITDAsted 1000 Adj A Adj B Reported PAT Adj A Adj B Adj C Adj D Adjusted PAT EBITDA FX gain EBITDA Adj A - Earnouts under acquisition agreements and for PAT it is adjusted for tax Adj B - Share based payment awards (non-cash expenses for the company and not tax deductible) Adj C - Amortization of intangible assets (net of tax) that got created due to carveout of healthcare business from HGS & acquisitions 17 Adj D- Exceptional items for Q1 FY27 represents adjustment for increase in past service cost of gratuity and compensated absence on account of increase in minimum wage in Karnataka & Telangana Go Forward Positions Amt in ₹ M Particulars FY26 FY27 FY28 FY29 FY30 FY31 FY32 Closing Debt position 5,670 - - - - - - Debt Repayment 2,350 5,670 - - - - - Interest Payment 543 287 - - - - - Share based Payment awards 122 166 74 39 - - - Earnouts Cost 475 64 95 19 - - - Intangibles Amortisation (A) 1,462 1,565 1,565 1,565 1,565 1,565 1,565 Intangibles Amortisation (B) 392 473 473 393 345 284 250 Debt to be fully repaid in current Financial year Earnout Costs: FY26 includes payouts for DCI, Birch, and BroadPath; FY27 relates to BroadPath and CareSeed; and FY28–FY29 represent CareSeed earnouts only Intangibles Amortization (A) - Amortization of intangible assets that got created due to carveout of healthcare business from HGS Intangibles Amortization (B) - Amortization for intangible assets acquired in relation to acquisitions (DCI, Birch, BroadPath and CareSeed) – Ends by FY36 Balance Sheet – 30th Jun 26 Amt in ₹ M Particulars Jun 26 Mar 26 Property, plant and equipment 4,609 4,624 Right-of-use assets 4,612 4,868 Goodwill 65,591 64,051 Other intangible assets 20,515 20,407 Trade receivables and unbilled 17,502 18,390 Cash and cash equivalents (including investments) 9,674 9,038 Deferred tax assets (net) 1,455 1,514 Other Assets 3,926 3,114 Total Assets 127,884 126,011 Equity 99,265 96,591 Borrowings 5,777 5,776 Lease liabilities 5,114 5,330 Trade payables 2,072 2,217 Deferred tax liabilities (net) 4,049 4,211 Other Liabilities 11,607 11,887 Total Equity & Liabilities 127,884 126,011 Cash Flow – Q1 FY27 Amt in ₹ M Particulars Q1 FY27 FY26 Profit before tax for the period/ year 2,875 12,389 Adjustment for Non-Operating and Non-Cash items 1,666 5,271 Adjustment for working capital (1,060) (1,895) Income taxes paid (net of refunds) (319) (3,735) Net cash flows generated from operating activities (A) - OCF 3,161 12,030 Addition to Fixed Assets (745) (1,922) Free Cash flow (FCF) 2,416 10,108 Cash paid for M&A (1,360) - Investment in Mutual fund and Fixed Deposit 562 (5,370) Others 51 185 Net cash flows (used in) investing activities (B) (1,493) (7,107) Repayment of Promoter borrowings (include Interest) (112) (2,937) Repayment of lease liabilities (include Interest) (454) (1,843) Dividend paid - (234) Net cash flows (used in) financing activities (C) (566) (5,014) Net increase/ (decrease) in cash and cash equivalents (A+B+C) 1,102 (91) Cash and cash equivalents at the beginning of the year/period 3,579 3,438 Cash and cash equivalents received as part of the CareSeed acquisition 23 - Effect of movement in exchange rates on cash and cash equivalents 3 233 Cash and cash equivalents at the end of the year/ period 4,707 3,579 Net cash flows generated from operating activities % (OCF on Reported EBITDA) 69.9% 64.7% Free Cash flow % (FCF on Reported EBITDA) 53.4% 54.4%